Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27087843 | 0.97 | F2 (0.33) | F2ALDH1A1MAPTHPGDKDM4E | |
| SCHEMBL13829458 | 0.97 | F2 (0.39) | F2ALDH1A1MAPTHPGDKDM4E | |
| Hydrochloric Acid SCHEMBL17386512 | 0.95 | F2 (0.37) | F2ALDH1A1MAPTCA12CA1 | |
| SCHEMBL152188 | 0.91 | F2 (0.30) | F2 | |
| SCHEMBL20578267 | 0.91 | F2 (0.30) | F2 | |
| SCHEMBL25257397 | 0.89 | F2 (0.33) | F2ALDH1A1 | |
| SCHEMBL597131 | 0.89 | F2 (0.33) | F2ALDH1A1 | |
| SCHEMBL22194142 | 0.84 | MAPT (0.33) | MAPT | |
| SCHEMBL13319270 | 0.81 | MEN1 (0.39) | ALDH1A1HPGDTP53HSD17B10CA12 | |
| SCHEMBL13864168 | 0.72 | ALDH1A1 (0.35) | F2ALDH1A1MAPTHPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624011-B2 | Oxadiazole derivative | Sumitomo Pharma Co., Ltd. (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4122923-B1 | OXADIAZOLE DERIVATIVE | SUMITOMO PHARMA CO LTD (JP) | 2025-09-10 | — | — | EP | disclosed |
| US-20250197353-A1 | METHOD OF FORMING BOND BY COUPLING REACTION | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-06-19 | — | — | US | disclosed |
| EP-4387980-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | Pardes Biosciences, Inc. (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-4320107-A1 | DOPANTS FOR ELECTRONIC COMPONENTS, THEIR USE IN ELECTRONIC COMPONENTS, AND ELECTRONIC COMPONENTS WITH SUCH DOPANTS | Heliatek GmbH (DE) | 2024-02-14 | — | — | EP | disclosed |
| US-11833219-B2 | Method for producing antibody-drug conjugate intermediate by addition of acid and use thereof | MABPLEX INTERNATIONAL CO., LTD. (CN) | 2023-12-05 | — | — | US | disclosed |
| US-20230265061-A1 | OXADIAZOLE DERIVATIVE | Sumitomo Pharma Co., Ltd. (JP) | 2023-08-24 | — | — | US | disclosed |
| US-11718592-B2 | Oxadiazole derivative | Sumitomo Pharma Co., Ltd. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20230203087-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2023-06-29 | — | — | US | disclosed |
| US-20230203484-A1 | DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO | WAVE LIFE SCIENCES LTD. (SG) | 2023-06-29 | — | — | US | disclosed |
| US-8309294-B2 | — | — | 2012-11-13 | — | — | US | disclosed |
| US-7829270-B2 | Photosensitive material, method of manufacturing conductive metal film, conductive metal film and light-transmitting film shielding electromagnetic wave for plasma display panel | FUJIFILM CORPORATION (JP) | 2010-11-09 | — | — | US | disclosed |
| US-7829270-B2 | Photosensitive material, method of manufacturing conductive metal film, conductive metal film and light-transmitting film shielding electromagnetic wave for plasma display panel | FUJIFILM CORPORATION (JP) | 2010-11-09 | — | — | US | disclosed |
| US-20090268186-A1 | PATTERN EXPOSURE METHOD AND PATTERN EXPOSURE APPARATUS | FUJIFILM CORPORATION (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20090268186-A1 | PATTERN EXPOSURE METHOD AND PATTERN EXPOSURE APPARATUS | FUJIFILM CORPORATION (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20090017277-A1 | comprising a support; and an emulsion layer containing a silver salt emulsion, the photosensitive material being capable of forming a conductive metal film by exposing and developing the emulsion layer, wherein the emulsion layer has a swelling rate of 150% or more | FUJIFILM CORPORATION (JP) | 2009-01-15 | — | — | US | disclosed |
| US-20090017277-A1 | comprising a support; and an emulsion layer containing a silver salt emulsion, the photosensitive material being capable of forming a conductive metal film by exposing and developing the emulsion layer, wherein the emulsion layer has a swelling rate of 150% or more | FUJIFILM CORPORATION (JP) | 2009-01-15 | — | — | US | disclosed |
| US-20080318155-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR AND PLATE MAKING METHOD | FUJIFILM CORPORATION (JP) | 2008-12-25 | — | — | US | disclosed |
| EP-1879887-A2 | NPY ANTAGONISTS, PREPARATION AND USE | Cerep (FR) | 2008-01-23 | — | — | EP | disclosed |
| WO-2006108965-A2 | NPY ANTAGONISTS, PREPARATION AND USE | CEREP (FR) | 2006-10-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718592-B2 | Oxadiazole derivative | OXA1L, SCN1A, CACNA1A | F2 1252/4885ALDH1A1 305/4885MAPT 1620/4885 |
| US-11833219-B2 | Method for producing antibody-drug conjugate intermediate by addition of acid and use thereof | AURKA, AURKC, CA14 | F2 2663/4885ALDH1A1 282/4885MAPT 886/4885 |
| US-20230203087-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | RNGTT, NSUN2, ALKBH1 | F2 4870/4885ALDH1A1 1901/4885MAPT 4649/4885 |
| US-20230265061-A1 | OXADIAZOLE DERIVATIVE | OXA1L, SCN1A, CACNA1A | F2 1252/4885ALDH1A1 305/4885MAPT 1620/4885 |
| US-12624011-B2 | Oxadiazole derivative | HSD3B1, CBR3, CBR1 | F2 2304/4885ALDH1A1 568/4885MAPT 4111/4885 |
| US-20250197353-A1 | METHOD OF FORMING BOND BY COUPLING REACTION | CBR1, CBR3, NOX4 | F2 9/4885ALDH1A1 1855/4885MAPT 4530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.